glp-1 obesity drug news today september 2025 Alarming rise in weight loss overdoses GLP-1 Agonists Weight Loss Drugs

PubMed pubmed.ncbi.nlm.nih.gov [31] Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist, a step forward in the treatment of diabetes and obesity

There is no representation or warranty as to the accuracy of the information and Penn Mutual Asset Management shall have no liability for decisions based upon such information

Administration: Once-weekly injection

doi: 10.1111/j.1432-1033.1984.tb08595.x 18 JrnvallHCarlquistMKwaukSOtteSCMcIntoshCHBrownJCet al

Targeting Glucose-Dependent Insulinotropic Polypeptide Receptor for Neurodegenerative Disorders

However, this fear is based on a misunderstanding of how these medications function